FBODaily.com | FedBizOpps: MOD | A | MicroRNA sequencing in conjunction with the Government’s Study of Translational Biomarkers for Drug-Induced Liver Injury (DILI) with Next-Generation Sequencing (NGS) - Responses to Questions

FBO DAILY - FEDBIZOPPS ISSUE OF APRIL 24, 2014 FBO #4534
MODIFICATION

A -- MicroRNA sequencing in conjunction with the Government’s Study of Translational Biomarkers for Drug-Induced Liver Injury (DILI) with Next-Generation Sequencing (NGS) - Responses to Questions

Notice Date: 4/22/2014
Notice Type: Modification/Amendment
NAICS: 541711 — Research and Development in Biotechnology
Contracting Office: Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
ZIP Code: 20857-0001
Solicitation Number: FDA-14-223-SOL-1128162
Archive Date: 5/10/2014
Point of Contact: Sondea R Blair, Phone: 8705437469
E-Mail Address: sondea.blair@fda.hhs.gov
(sondea.blair@fda.hhs.gov)
Small Business Set-Aside: N/A
Description: Responses to Questions
Web Link: FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-14-223-SOL-1128162/listing.html)
Place of Performance: Address: National Center for Toxicological Research, 3900 NCTR Road, Jefferson, Arkansas, 72079, United States; Zip Code: 72079
Record: SN03345292-W 20140424/140422235013-ccbbcf4084c4f5d97f3b38f91943e8b3 (fbodaily.com)
Source: FedBizOpps Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's FBO Daily Index Page |